2022
DOI: 10.24272/j.issn.2095-8137.2021.387
|View full text |Cite
|
Sign up to set email alerts
|

Characterization of two novel knock-in mouse models of syndromic retinal ciliopathy carrying hypomorphic <i>Sdccag8</i> mutations

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 46 publications
0
1
0
Order By: Relevance
“…To elucidate the pathogenesis of PKD and test the efficacy of the candidate drugs, spontaneous and genetically modified laboratory animal models are the primary source of development information. The revelation of the nucleotide sequences of PKD1 , PKD2 , and PKHD1 has led to the development of various genetically modified animals, including transgenic animals with a foreign gene inserted, knockout (KO) animals with a specific gene disrupted, conditional KO (CKO) animals with cells forming a specific organ intentionally damaged or genetically disrupted at specific locations, knock-in animal models with hypomorphic genetic mutations, and genome-editing animal models that have been modified using new techniques such as the CRISPR/Cas9 method [ 16 , 17 , 18 , 19 ]. This study introduces the use of animal models in research on renal cystic disease and characterizes different animal model strains.…”
Section: Introductionmentioning
confidence: 99%
“…To elucidate the pathogenesis of PKD and test the efficacy of the candidate drugs, spontaneous and genetically modified laboratory animal models are the primary source of development information. The revelation of the nucleotide sequences of PKD1 , PKD2 , and PKHD1 has led to the development of various genetically modified animals, including transgenic animals with a foreign gene inserted, knockout (KO) animals with a specific gene disrupted, conditional KO (CKO) animals with cells forming a specific organ intentionally damaged or genetically disrupted at specific locations, knock-in animal models with hypomorphic genetic mutations, and genome-editing animal models that have been modified using new techniques such as the CRISPR/Cas9 method [ 16 , 17 , 18 , 19 ]. This study introduces the use of animal models in research on renal cystic disease and characterizes different animal model strains.…”
Section: Introductionmentioning
confidence: 99%